RBX2660 Reduces Recurrent C difficile Infections in Patients With Comorbid Conditions
Bacterial Infections General General Infectious Diseases Microbiome News Treatments

RBX2660 Reduces Recurrent C difficile Infections in Patients With Comorbid Conditions

Treatment with investigational, microbiota-based, live biotherapeutic RBX2660 reduced recurrent Clostridioides difficile infection (rCDI) in patients with rCDI and comorbid conditions, according to research presented at the American College of Gastroenterology (ACG) 2021 Annual Meeting, held…

Incidence of Vaccine-Related and Nonvaccine Human Papillomavirus Types Among Adolescent Girls, Young Women in New York City
General General Infectious Diseases Human Papillomavirus Immunization News Sexually Transmitted Infections Vaccines

Incidence of Vaccine-Related and Nonvaccine Human Papillomavirus Types Among Adolescent Girls, Young Women in New York City

After the rollout of the human papillomavirus (HPV) vaccination program in New York City, the rates of vaccine-related HPV types decreased but nonvaccine high-risk HPV types increased among adolescent girls and young women, according to…